Toxic agents, detection, protection and decontamination specialists.
Loading organisations…
Clear filters
5 organisations in Chemical
Sort Best match · Name
Defender Pharmaceuticals holds an exclusive licence to develop an injectable dimethyl trisulfide cyanide antidote, potentially as an autoinjector, based on work at a US Army laboratory.
Rafa Laboratories, based in Jerusalem, manufactures emergency medical countermeasures including a 2 mg atropine auto-injector, FDA-approved in July 2018, for poisoning by organophosphate nerve agents and some insecticides. It supplies the product to US government and NATO member states.
Crossject is a French maker of needle-free auto-injectors. Under a BARDA Project BioShield partnership it is developing ZENEO midazolam autoinjectors for emergency use, such as nerve-agent seizures.
Kaléo develops auto-injector products including a nerve-agent antidote under government funding. CBRNE-relevant work is a notable product line according to its website.
Kindeva Drug Delivery supplies auto-injectors for nerve-agent antidote stockpiles. CBRNE-relevant work is a notable product line according to its website.